People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clarify Medical, Inc. | — | Healthtech | Series C | $67.6M | $776.1M | 2021 |
Edward Fulham at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward Fulham on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David F Hale | 1 | 16 |
| PAUL LAVIOLETTE | 1 | 12 |
| Robert Garber | 1 | 8 |
| Bruce Robertson | 1 | 7 |
| John Schellhorn | 1 | 4 |
| David Hale | 1 | 4 |
| Rex Bright | 1 | 3 |
| George Mahaffey | 1 | 2 |
| John Buhler | 1 | 2 |
| John T. Buhler | 1 | 1 |
| James M. Sweeney | 1 | 1 |
| Donald Canal | 1 | 1 |
| David T. Hale | 1 | 1 |
| Amit F. Pandya, M.D. | 1 | 1 |
| Rex M. Bright | 1 | 1 |
| Charlene M. Kakimoto, M.D. | 1 | 1 |
| Martyn Gross | 1 | 1 |
| Kathy Scott | 1 | 1 |
| Kathleen Scott | 1 | 1 |
| Edward M. Fulham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.